Text Size
7 studies found for:    Open Studies | "Carcinoma, Merkel Cell"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Not yet recruiting Dose Escalation Study to Investigate Safety, PK and Anti-tumor Activity of Pasireotide in Patients With Metastatic Melanoma or Merkel Cell Carcinoma
Condition: Metastatic Melanoma and Merkel Cell Carcinoma
Intervention: Drug: Pasireotide sub-cutaneous formulation
2 Recruiting Merkel Positron Emission Tomography (PET) Protocol
Condition: Merkel Cell Carcinoma
Interventions: Drug: Carboplatin;   Drug: Etoposide;   Radiation: Radiotherapy
3 Recruiting Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer
Conditions: Melanoma;   Merkel Cell Carcinoma;   Squamous Cell Carcinoma;   Penile Carcinoma;   Urethral Carcinoma;   Extramammary Paget's Disease;   Scrotal Carcinoma;   Anal Cancer;   Vulvar Cancer;   Skin Cancer;   Lymphadenopathy
Interventions: Procedure: Videoscopic procedure;   Procedure: Open, traditional approach
4 Recruiting Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma
Conditions: Recurrent Neuroendocrine Carcinoma of the Skin;   Stage IV Neuroendocrine Carcinoma of the Skin
Interventions: Biological: aldesleukin;   Other: laboratory biomarker analysis;   Radiation: radiation therapy;   Biological: recombinant interferon beta;   Biological: MCPyV TAg-specific polyclonal autologous CD8-positive T cell vaccine
5 Recruiting Interleukin-12 Gene and in Vivo Electroporation-Mediated Plasmid DNA Vaccine Therapy in Treating Patients With Merkel Cell Cancer
Conditions: Recurrent Neuroendocrine Carcinoma of the Skin;   Stage I Neuroendocrine Carcinoma of the Skin;   Stage II Neuroendocrine Carcinoma of the Skin;   Stage III Neuroendocrine Carcinoma of the Skin;   Stage IV Neuroendocrine Carcinoma of the Skin
Interventions: Biological: interleukin-12 gene;   Biological: electroporation-mediated plasmid DNA vaccine therapy;   Other: laboratory biomarker analysis
6 Not yet recruiting Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors
Conditions: Metastatic Gastrointestinal Carcinoid Tumor;   Pulmonary Carcinoid Tumor;   Recurrent Gastrointestinal Carcinoid Tumor;   Recurrent Neuroendocrine Carcinoma of the Skin;   Regional Gastrointestinal Carcinoid Tumor;   Stage III Neuroendocrine Carcinoma of the Skin;   Stage IV Neuroendocrine Carcinoma of the Skin;   Thyroid Gland Medullary Carcinoma
Interventions: Drug: pazopanib hydrochloride;   Other: placebo;   Procedure: quality-of-life assessment;   Other: laboratory biomarker analysis
7 Recruiting Capecitabine and Temozolomide for Neuroendocrine Cancers
Condition: Neuroendocrine Tumors
Intervention: Drug: Capecitabine and temozolomide
To Top

† Indicates status has not been verified in more than two years